Faruqi and Faruqui, LLP Logo
Share this page

AngioDynamics, Inc. (ANGO)

NASDAQ:ANGO

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (NASDAQ:ANGO).

The investigation focuses on whether the Company and its executives violated federal securities laws.  Specifically, after market on July 17, 2017, the Company filed a Form 8-K with the Securities and Exchange Commission disclosing, among other things, that its former independent registered public accounting firm has “determined that there was a material weakness in the Company’s internal control over financial reporting as of May 31, 2016 because the Company did not design and maintain effective internal controls over the accounting for the annual goodwill impairment test.”

On this news, the Company’s share price declined, causing harm to investors.

If you invested in AngioDynamics stock or options and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    AngioDynamics, Inc. (ANGO)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 07/18/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.